Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

Restructuring, Sub-Division & Consolidation Update

6 Feb 2023 16:48

RNS Number : 0748P
Nostrum Oil & Gas PLC
06 February 2023
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Β 

Β 

London, 6 February 2023

Β 

Restructuring, Sub-Division and Consolidation Update

Β 

Nostrum Oil & Gas PLCΒ (LSE: NOG) ("Nostrum" or the "Company"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, provides a further update to the proposed restructuring of the Group's US$725 million 8.0% Senior Notes due July 2022 and the US$400 million 7.0% Senior Notes due February 2025, in each case issued by Nostrum Oil & Gas Finance B.V. (the "Restructuring").

Β 

At the Nostrum general meeting held on 29 April 2022, Nostrum shareholders approved, among other things, the sub-division of ordinary shares in the capital of Nostrum with a nominal price of 1 pence ("Shares") and a 10:1 consolidation of the Shares (the "Sub-Division and Share Consolidation") in connection with the Restructuring. The Sub-Division and Share Consolidation are to occur immediately after the allotment of the 1,505,633,046 new Shares ("New Shares") in accordance with the Restructuring.

Β 

It is anticipated that the Restructuring will be effected on Thursday, 9 February 2023. Accordingly, the record date for the Sub-Division and Share Consolidation will be Nostrum shareholders on the register at close of business on 9 February 2023.

Β 

The Sub-Division and Share Consolidation is expected to take place after the market closes on Thursday, 9 February 2023 and it is expected that admission and dealings in the consolidated Shares on the London Stock Exchange (LSE) will commence at 8.00 a.m. (GMT) on Friday, 10 February 2023.

Β 

Immediately following the Sub-Division and Share Consolidation, the Company will have a total issued share capital of up to 169,381,599 Shares and 15,244,344,036 deferred shares. As part of the Share Consolidation process, a new ISIN in respect of the Shares will become effective from Share Consolidation. The existing ISIN of the existing ordinary shares (GB00BGP6Q951) will be cancelled and, following the Share Consolidation, the Shares (which include the New Shares being issued under the Restructuring) will have a new ISIN of GB00BQVVS097.

Β 

Further information on and key dates in relation to the Restructuring, Sub-Division and Share Consolidation is set out below ("Expected Timetable of Principal Events"):

Β 

Expected Timetable of Principal Events

Β 

The dates given in the table below are indicative only and are based on the Company's current expectations and may be subject to change without notice. All times shown are in London times unless otherwise stated and capitalised terms used but not defined in this table have the meaning given to them in the Explanatory Statement. References to "COB" means close of business.

Β 

Event

Date

Issue of New Notes, Debt for Equity Swap, and Sub-Division and Share Consolidation

9 February 2023

Effective Date of the Restructuring

9 February 2023

Record date for the Sub-Division and Share Consolidation

COB on 9 February 2023

LSE Admission

10 February 2023

Crediting of New Shares to CREST accounts in uncertificated form

10 February 2023

AIX Admission

13 February 2023

Despatch of definitive share certificates in respect of New Shares (where applicable)

By no later than 14 days from Admission/AIX Admission

De-listing from KASE

By 10 March 2023

Β 

LEI: 2138007VWEP4MM3J8B29

Β 

Further information

For further information please visit www.nostrumoilandgas.comΒ 

Β 

Further enquiries:

Nostrum Oil & Gas PLC

Thomas Hartnett - Chief Legal Officer / Company Secretary

ir@nog.co.uk

Β 

White & Case LLP

Allan Taylor (ataylor@whitecase.com)

+44 (0) 207 532 1000

WCProjectNewport@whitecase.com Β 

Β 

Instinctif Partners - UK

Tim McCall

Galyna Kulachek

Vivian Lai

+ 44 (0) 207 457 2020

nostrum@instinctif.com

Β 

Notifying person

Thomas Hartnett

Company Secretary

Β 

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG) and the Kazakhstan Stock Exchange (ticker symbol: GB_NTRM). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field, that is being operated by a wholly-owned subsidiary of Nostrum Oil & Gas PLC - Zhaikmunai LLP, who is the sole holder of the subsoil use rights with respect to the development of the field.

Β 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

Β 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

Β 

Disclaimer

This announcement is not intended to and does not constitute or form part of any offer to sell or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the proposals set out herein or otherwise, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor or be considered a recommendation that any investor should subscribe for or purchase or invest in any securities.

Any such offer or invitation will be made solely by means of a prospectus as supplemented by a supplementary prospectus to be published by the Company in due course. This announcement has not been examined or approved by theΒ FCAΒ or any other regulatory authority. The distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

The securities referred to herein have not been and will not be registered under the US Securities Act of 1933 as amended (the "Securities Act") or under any US state securities laws and may not be offered or sold withinΒ the United StatesΒ unless any such securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act and any applicable state laws is available.

Neither the content of the Company's website nor any website accessible by hyperlinks to the Company's website is incorporated in, or forms part of, this announcement.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCDZGGZVVVGFZM
Date   Source Headline
11th Jun 20265:47 pmRNSNotification of interest payments on the Notes
1st Jun 20267:00 amRNSPublication of Annual Report and Notice of AGM
26th May 20267:09 amRNS1st Quarter Results
14th May 202610:59 amRNSUpdate re Kazakhstan withholding tax disputes
7th May 20265:11 pmRNSBoard Change
30th Apr 20267:00 amRNSOperational Update for Q1 ended 31 March 2026
29th Apr 20267:00 amRNSFull Year Results
30th Mar 202611:38 amRNSProposed Transaction
17th Feb 202611:51 amRNSFurther update on Kazakhstan withholding tax
9th Feb 20269:17 amRNS-RUpdate re Kazakhstan withholding tax disputes
9th Feb 20267:00 amRNSBoard Committee Changes
3rd Feb 20269:38 amRNS-RUpdate on Kazakhstan withholding tax disputes
30th Jan 20267:00 amRNSOperational Update for Q4 and FY2025
26th Jan 202612:18 pmRNSBoard Change
2nd Jan 20268:30 amRNSNotice of delayed interest payments on notes
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
25th Nov 20257:00 amRNSFinancial results for Q3 and 9M 2025
21st Nov 20257:00 amRNSAppointment of NED and Board Committee Changes
31st Oct 202511:27 amRNSBoard Committee Change
31st Oct 20257:00 amRNSOperational Update for 3Q and 9M 2025
24th Oct 20257:00 amRNSAppointment of a NED and Board Committee Changes
17th Oct 20257:00 amRNSAppointment of Nikolay Ivin as Chairman
6th Oct 202510:57 amRNSConsent Solicitation Results
24th Sep 202510:02 amRNSConsent Solicitation
19th Sep 202512:38 pmRNSNew CFO
16th Sep 20254:35 pmRNSConsent solicitation results at early consent date
16th Sep 20253:40 pmRNSMaterial related party transaction and new COO
2nd Sep 20255:23 pmRNSConsent solicitation re payment delay on notes
29th Aug 20257:00 amRNSFinancial results for Q2 and 6M ended 30 June 2025
31st Jul 20257:00 amRNSOperational Update for Q2 and H1 2025
30th Jul 20259:19 amRNSUpdate: delayed interest payments,proposed actions
22nd Jul 20253:33 pmRNSUpdate: delayed interest payments,proposed actions
15th Jul 20255:37 pmRNSAppointment of CEO and a Non-Executive Director
10th Jul 202511:38 amRNSNotification of delayed interest payments
30th Jun 20251:48 pmRNSStakeholder discussions and Board changes
30th Jun 202512:18 pmRNSResult of AGM
6th Jun 202511:43 amRNSPublication of Annual Report and Notice of AGM
20th May 20257:00 amRNS1st Quarter Results
30th Apr 20257:00 amRNSOperational Update for Q1 2025
25th Apr 20253:25 pmRNS2024 Report on Payments to Governments
23rd Apr 20257:00 amRNSFull Year Results
10th Apr 20253:20 pmRNSTR-1: Notification of major holdings
7th Apr 20258:41 amRNSShares Cancellation, Change in Total Voting Rights
4th Apr 20257:00 amRNSApproval of Stepnoy Leopard Field Development Plan
21st Mar 20257:00 amRNSProcessing Agreement extension with Ural Oil & Gas
6th Feb 202511:52 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSOperational Update for Q4 and FY2024
12th Dec 202412:01 pmRNSHolding(s) in Company
2nd Dec 20244:17 pmRNSPurchase and Cancellation of Deferred Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.